COMT helps metabolize catechol compounds by transferring a methyl group from SAM. Its substrates include dopamine, epinephrine, norepinephrine, and hydroxylated estrogen metabolites called catechol estrogens.
The most searched COMT variant is Val158Met, also called rs4680 or Val108/158Met. The Met form is less stable than the Val form. In postmortem human prefrontal cortex, Met/Met samples had about 40% lower COMT activity than Val/Val samples, while Val/Met samples were intermediate.
Studies have reported associations between Val158Met and working memory, attention, stress response, pain, and psychiatric traits. Other studies and meta-analyses have found little or no association for many of the same outcomes. The variant may contribute to average group differences under some conditions, but it does not produce a reliable personality profile or individual forecast by itself.
What the COMT gene does
The NCBI Gene record for COMT describes two protein forms. The longer membrane-bound form is the main form in the brain. A shorter soluble form is more prominent in tissues such as the liver, kidneys, and blood.
Membrane-bound COMT has been found in neuronal cell bodies, axons, dendrites, and glial cells. Studies disagree about whether its catalytic domain faces the cytoplasm or the extracellular space, so it is inaccurate to describe COMT as an enzyme located only inside synapses.
COMT has a larger role in dopamine clearance in the PFC than in regions where the DAT is abundant. DAT expression is relatively sparse in the prefrontal cortex, leaving more dopamine to be cleared through other routes, including COMT.
COMT and estrogen metabolites
COMT also methylates catechol estrogens such as 2-hydroxyestradiol and 4-hydroxyestradiol, producing methoxyestrogens. This is one route for handling estrogen metabolites that contain a catechol structure.
COMT does not perform the earlier conversion of estradiol into catechol estrogens; cytochrome P450 enzymes carry out that hydroxylation step. COMT therefore participates in estrogen-metabolite clearance, but a COMT genotype alone cannot describe a person's overall estrogen production, estrogen clearance, hormone levels, or cancer risk.
The COMT variant people search for
Val158Met is the common COMT variant most consumer reports highlight. It changes one amino acid in the longer COMT enzyme from valine to methionine at position 158. In the shorter form, the same change is often written as Val108Met.
| Common protein result | Careful interpretation | What not to conclude |
|---|---|---|
| Val/Val | Often associated with higher COMT enzyme activity in functional studies. | Some studies report trait differences, but this does not guarantee a warrior profile or high stress resilience. |
| Val/Met | Often treated as an intermediate activity pattern. | Do not assume it averages out every other pathway or clinical factor. |
| Met/Met | Often associated with lower COMT enzyme activity. | Reported trait associations do not make this an anxiety diagnosis or a supplement instruction. |
Raw DNA files may report letters such as G and A instead of Val and Met. Strand, genome build, transcript, and report conventions matter, so the protein notation and rsID should be confirmed before using the result.
The wider COMT evidence map
rs4680 is not the only COMT variant worth reviewing. The strongest reason to look beyond it is that nearby variants can travel together as a haplotype. A functional study of rs6269, rs4633, rs4818, and rs4680 found that the four-variant haplotype affected COMT messenger RNA structure, protein expression, and enzyme activity. Reading rs4680 alone can therefore hide part of the functional pattern.
The table focuses on variants with measured effects on COMT RNA, protein, or enzyme activity. It separates those molecular findings from broader trait associations, which may depend on the haplotype, tissue, ancestry, sex, and study design.
| Variant or haplotype | Measured molecular effect | Research context |
|---|---|---|
| rs4680, Val158Met | The Met form is less stable. In postmortem prefrontal cortex, Met/Met samples had about 40% lower COMT activity than Val/Val samples, with Val/Met in between. | The effect has been measured directly in human brain tissue and in recombinant protein experiments. |
| rs6269, rs4633, rs4818, and rs4680 | These four markers form common haplotypes with different messenger RNA stem-loop structures. The altered RNA folding changes how much COMT protein is translated and therefore changes enzyme activity. | In a laboratory expression system, the high-activity GCGG haplotype produced about 18 to 25 times the activity of the low-activity ACCG haplotype. |
| rs737865 and rs165599 | A haplotype containing these noncoding variants was associated with lower allele-specific COMT messenger RNA expression in human brain samples. | A later postmortem study did not find an independent effect from either marker alone, which supports reading them as part of a haplotype rather than as isolated switches. |
| rs2075507, formerly rs2097603 | This promoter-region variant changes regulation of the brain-predominant membrane-bound COMT transcript. | The minor allele was associated with about a 1.5-fold reduction in lymphocyte COMT activity independent of rs4680, with a smaller effect also seen in postmortem brain. |
| Ala22Ser | Recombinant soluble COMT carrying Ala22Ser showed lower methylation capacity and lost activity more readily with heat. | This is a direct protein experiment. It identifies a stability defect, although it does not establish how large the effect is in each human tissue. |
Functional experiments show what a variant did to RNA or protein under specific laboratory conditions. Association studies only show that a genotype and an outcome occurred together in a study population. Association findings are more vulnerable to chance, population differences, and unmeasured factors, so they should not be read as direct biological effects.
About warrior and worrier labels
Some consumer articles call Val/Val the warrior type and Met/Met the worrier type. The labels grew out of real research on cognition and performance under stress, but they are not clinical categories. Results vary with the task, stress level, age, sex, ancestry, health status, and other genes, and people with different genotypes overlap substantially.
COMT may be relevant to how a reviewer thinks about catecholamine handling, but mood, attention, pain, and stress response involve many genes, medications, sleep patterns, hormones, medical conditions, and life context. MedlinePlus notes that complex neuropsychiatric traits involve many genetic and lifestyle factors.
Nutrients that support COMT activity
COMT needs SAM as its methyl donor and magnesium at its active site. The folate and methionine cycles help maintain the supply of SAM, while adequate magnesium supports the catalytic reaction itself. A recent mouse experiment also found that dietary magnesium deficiency reduced liver COMT activity.
A COMT genotype can therefore be useful when reviewing methyl-donor availability, homocysteine, diet, and magnesium status. The practical question is whether the person has an actual dietary or biochemical shortfall. The genotype does not show SAM or magnesium levels, and it does not prove that a high-dose methyl donor or magnesium supplement will improve symptoms.
Supplement decisions should account for diet, relevant laboratory findings, kidney function, medications, symptoms, and total dose. The NIH National Center for Complementary and Integrative Health notes that supplements can interact with medications and may carry risks for some people.
What the genotype leaves unanswered
- It does not diagnose anxiety, ADHD, depression, pain disorders, estrogen problems, or methylation problems.
- It does not measure dopamine, norepinephrine, epinephrine, homocysteine, estrogen metabolites, or nutrient status.
- It does not show whether SAM production or magnesium status is adequate. Those questions require diet, laboratory, medication, and clinical context.
- It does not replace a clinical history, exam, lab testing, medication review, or family history.
How Gene Inspector Pro looks deeper
Gene Inspector Pro shows the exact COMT findings in an uploaded file and keeps variant identity separate from evidence strength. This prevents a broad "COMT type" label from hiding other calls, and it prevents a small association study from being presented like a measured enzyme effect.
File type also matters. A SNP array may include rs4680 but miss other COMT positions. WES mainly covers protein-coding exons, so it can miss promoter and deep intronic variants. WGS covers a broader range of positions, but coverage, genotype quality, and filtering still need review. Related genes in catecholamine synthesis, transport, and breakdown may also matter, depending on the question.
GIP cannot calculate dopamine levels or diagnose a condition from COMT. It can show which variants are actually present, what kind of evidence exists for each one, and where the source file leaves gaps.
COMT review checklist
| Review step | What to check | Why it matters |
|---|---|---|
| Confirm the variant | rsID, protein notation, transcript, and strand conventions. | Prevents confusing Val/Met labels with raw base calls. |
| Check the source file | SNP array, WGS, WES, coverage, and genotype quality. | A missing or low-quality call can mislead the review. |
| Read frequency and databases | Population frequency and ClinVar when available. | Shows whether a variant is common, rare, reviewed, or uncertain. |
| Review the clinical context | Symptoms, labs, medication list, supplement use, and family history. | COMT variants can meaningfully shift enzyme stability and average activity. Clinical context shows how that inherited shift may be expressed in this person. |
| Look beyond one gene | Related catecholamine, methylation, hormone, and drug-response genes when relevant. | Single-gene explanations are usually too narrow. |
Related review pages
For variant review basics, read how to read the Gene page, allele frequency and MAF in variant review, and what a missense variant is. For file limits, compare SNP arrays with WGS and WES files. For hormone-pathway context, see estrogen-related genes and hormone metabolism.
Sources
- NCBI Gene: COMT catechol-O-methyltransferase, for COMT gene name, chromosome context, enzyme function, methyl transfer, and catecholamine substrates.
- MedlinePlus Genetics: COMT gene, for plain-language COMT function, enzyme forms, prefrontal cortex context, and limits of interpreting complex traits.
- Chen et al., American Journal of Human Genetics, 2004, for functional analysis of COMT variation and Val158Met effects on protein abundance and enzyme activity.
- Nackley et al., Science, 2006, for COMT haplotype effects on messenger RNA structure, protein translation, and enzyme activity.
- Bray et al., Human Genetics, 2003, for allele-specific COMT expression in human brain and the rs737865-rs165599 haplotype.
- Zhu et al., Pharmacogenetics and Genomics, 2005, for reduced methylation capacity and heat stability of recombinant Ala22Ser COMT.
- Barnett et al., Biological Psychiatry, 2008, for a meta-analysis finding little or no association between Val158Met and most tested cognitive outcomes.
- Zareyan et al., Cerebral Cortex, 2021, for an experimental study in which mild stress affected executive performance differently by Val158Met genotype.
- Zhu et al., Drug Metabolism and Disposition, 2010, for human placental COMT methylation of catechol estrogens into methoxyestrogens.
- Schott et al., Frontiers in Psychiatry, 2010, for membrane-bound COMT expression in neurons and glial cells and evidence for intracellular orientation.
- Chen et al., Journal of Biological Chemistry, 2011, for membrane-bound COMT localization in neuronal cell bodies, axons, and dendrites, and evidence for extracellular catalytic orientation.
- Patil et al., Journal of the American Chemical Society, 2019, for the human COMT active-site complex containing SAM, magnesium, and a catechol substrate.
- Hirata et al., Diabetologia, 2025, for the mouse experiment in which dietary magnesium deficiency reduced liver COMT activity.
- NCCIH: Using Dietary Supplements Wisely, for supplement safety, medication interaction, and regulatory context.